Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MicroCarb

This article was originally published in The Tan Sheet

Executive Summary

Signs preliminary joint venture agreement with Hughes Labs covering OTC and prescription marketing rights to an unnamed drug for the treatment of cold sores and genital herpes. Gaithersburg, Md.-based MicroCarb plans to initially market the drug as an OTC treatment for cold sores while the company begins the clinical development process to support prescription marketing of the drug as a genital herpes treatment. The joint venture agreement also would cover three patents held by Hughes covering the antiviral product. MicroCarb has a 90-day period to obtain financing of a minimum of $5 mil. for the deal
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel